Routine PSA Screening May Do More Harm Than Good ++++++

News & Perspectives: Fast Five Quiz: Presentation and Diagnosis of Iron-Deficiency Anemia Fast Five Quiz: Presentation and Diagnosis of Iron-Deficiency Anemia Reviewed by Ruben Rhoades, MD, MS https://reference.medscape.com/viewarticle/anemia-presentation-and-diagnosis-2025a1000u76?ecd=wnl_edit_tpal_etid7984532&uac=148436CN&impID=7984532 The Year’s 10 Best Gastroenterology Guidelines The Year’s 10 Best Gastroenterology Guidelines David A. Johnson, MD https://www.medscape.com/viewarticle/years-10-best-gastroenterology-guidelines-2025a1000zqj?ecd=wnl_edit_tpal_etid7984532&uac=148436CN&impID=7984532 December 23, 2025 Hope for Huntington’s With Possible Breakthrough Gene Therapy Hope for Huntington’s With Possible Breakthrough Gene Therapy Andrew N. Wilner, MD; Victor Sung, MD https://www.medscape.com/viewarticle/hope-huntingtons-possible-breakthrough-gene-therapy-2025a1000zqb?ecd=wnl_edit_tpal_etid7984532&uac=148436CN&impID=7984532 December 23, 2025 Hereditary Angioedema: 5 Things to Know Hereditary Angioedema: 5 Things to Know Jonathan A. Bernstein, MD https://www.medscape.com/viewarticle/hereditary-angioedema-5-things-know-2025a1000t8t?ecd=wnl_edit_tpal_etid7984532&uac=148436CN&impID=7984532 December 23, 2025 ESMO: Pembrolizumab Neoadjuvant/Adjuvant Outperforms Adjuvant Alone in Stage III Melanoma ESMO: Pembrolizumab Neoadjuvant/Adjuvant Outperforms Adjuvant Alone in Stage III Melanoma Teresa Amaral, MD, PhD https://www.medscape.com/viewarticle/esmo-pembrolizumab-neoadjuvant-adjuvant-outperforms-adjuvant-2025a1000yk1?ecd=wnl_edit_tpal_etid7984532&uac=148436CN&impID=7984532 December 23, 2025 Routine PSA Screening May Do More Harm Than Good Routine PSA Screening May Do More Harm Than Good Kenneth W. Lin, MD, MPH https://www.medscape.com/viewarticle/routine-psa-screening-may-do-more-harm-than-good-2025a1000zqw?ecd=wnl_edit_tpal_etid7984532&uac=148436CN&impID=7984532 December 23, 2025